Sonidegib is used to treat basal cell carcinoma (BCC; a type of skin cancer) in adults with cancer that has come back after surgery or radiation, or in adults that cannot be treated with surgery or radiation<\/b>. Sonidegib is in a class of medications called hedgehog pathway inhibitors.<\/p>\nHow can 1 go about obtaining Sonidegib capsules?<\/h3>\n
If Sonidegib capsules\u00a0are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
Note:<\/strong> Generic Name – Relatlimab (Sonidegib) If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import sonidegib Capsules\u201d b<\/strong>ased on the information you provide.<\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n","protected":false},"excerpt":{"rendered":"Sonidegib capsules, for oral use Initial U.S. Approval: 2015<\/h2>\n
\nMedicine Type – Capsules \/ Oral
\nManufacturer Name – Sun Pharma Global Fze
\nApproval Year – 2015
\nApproved by – European Medical Agency (EMA), Food and Drug Administration (FDA), Therapeutic Goods Administration (TGA)<\/p>\nAccess the best support services globally<\/h4>\n